| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.01 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |